Affiliation:
1. Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, PA
2. Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA
3. Department of Medicine, Penn State College of Medicine, Hershey, PA
Abstract
OBJECTIVE
Women of childbearing potential are often excluded from participating in clinical trials owing to concerns about adverse fetal effects of treatment. This study aims to determine the prevalence of fertility-related exclusion criteria in clinical trials of type 2 diabetes medications and to determine whether these criteria are commensurate with drug risk.
RESEARCH DESIGN AND METHODS
ClinicalTrials.gov was queried for trials of type 2 diabetes medications that were phase 2 or 3, were based in the U.S., and enrolled participants 18–40 years old. Six hundred eighty-eight trials met criteria. Information collected about each trial included enrollment, trial length, exclusion and inclusion criteria, trial sponsor, and pregnancy category of drug(s) administered.
RESULTS
Most studies (59%) included one or more fertility-related exclusion criteria, most often excluding current pregnancy (55%) and breast-feeding (44%). Trials of medications with increased fetal risk were not more restrictive: trials of category C drugs (evidence of fetal risks in animals) were less likely to exclude pregnancy compared with trials of category B drugs (no known human or animal fetal risks) (45.6% vs. 69.8%, odds ratio [OR] 0.37 [95% CI 0.20, 0.65], P = 0.0005) or to require contraceptive use (29.9% vs. 57.1%, OR 0.32 [95% CI 0.18, 0.56], P = 0.001).
CONCLUSIONS
In clinical trials of type 2 diabetes medications, exclusion criteria affecting women of childbearing potential are often disproportionate to risk to the participant and fetus. These criteria have the potential to impede young women’s access to clinical trials and may hinder the acquisition of clinical knowledge critical for improving the care of women with diabetes.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference29 articles.
1. Diabetes in women [article online], 2014. Available from http://www.cdc.gov/diabetes/risk/gender/women.html. Accessed 1 May 2015
2. Status of women in cardiovascular clinical trials;Kim;Arterioscler Thromb Vasc Biol,2009
3. A patent extension proposal to end the underrepresentation of women in clinical trials and secure meaningful drug guidance for women;Hathaway;Food Drug Law J,2012
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献